P&U Zyvox Surveillance Program To Provide Resistance Data To Physicians
Pharmacia & Upjohn is developing a resistance surveillance program for physicians in conjunction with the future launch of its antimicrobial Zyvox.
You may also be interested in...
Rhone-Poulenc Rorer's injectable streptogramin antibiotic Synercid (quinupristin/dalfopristin) is expected to be launched in the U.K. by October, following approval by the Medicines Control Agency on July 29.
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011